Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis. The
Health7- Page
122Articles
The new weight-loss jab outperforms its competitors, including Ozempic. It helps obese patients lose four stone in under a year. Retatrutide acts on three receptors in the mind, “turbocharging”, calorie
The company says the decision was made purely for commercial reasons, as alternatives to jab have been developed. The Oxford-AstraZeneca Covid vaccination is being withdrawn from the market worldwide. This
According to a new report, millions of obese people cannot work or are less efficient. This condition may explain the record-high rates of economic inactivity in the UK due to
The number of workers who are out of work due to long-term illness has risen to a new record of over 2.8 million. Since the Covid pandemic began, economic inactivity
Scientists have called on countries to overhaul prostate cancer testing in order to focus more attention on vulnerable groups. New research predicts that global deaths due this disease will nearly
Indivior’s top shareholder — one of the largest institutional investors in the City — is unlikely oppose its plans to move to the United States. Indivior, a company that specializes
Most people prefer to take a pill rather than inject themselves with medication when they are sick. This simple fact helped Novo-Nordisk, (stock ticker:NOVO), to become the third-most valuable holding
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its
AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of
Smith & Nephew’s revival is taking hold, according to the chief executive of the FTSE 100 medical products maker after it posted better-than expected fourth-quarter financial results. The underlying revenue
The latest blow to London as a financial hub is the plan to relocate the primary listing of one of the largest anti-opioid companies in the world to the United
One of Britain’s largest drug companies secured a fast track review of a potentially blockbuster treatment of chronic hepatitis B. GSK announced that the US Food and Drug Administration has
Redx Pharma has decided to list in New York because it wants to tap into a wider and more specialized pool of investors. The latest blow for the City is
Scientists shed new light on the spread of Alzheimer’s disease in the brain, and discovered the first evidence that it can be transmitted between people via the now-banned growth hormone
Haleon sold ChapStick for more than $500m as it sought to reduce its debts while also boosting its stock price. The FTSE-100 company has agreed that it will sell its
